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We previously reported that catechins of green tea have different antiproliferative effects on cell
lines derived from gender-dependent cancers; epicatechin 3-gallate (ECG) had the strongest
inhibitory effect. In the present study, we examined the effects of epigallocatechin (EGC),
epicatechin-gallate (ECG) and EGC 3-gallate (EGCG) on the viability, density, doubling time
and cycle number of cell lines derived from melanoma metastasized to lymph nodes (MB-1133
and SE-0154) or distant organs (CH-0356, JK-0346, SA-1171, GE-0208, NS-1176 and
LF-0023). These catechins have been documented to have no growth suppressive or apoptotic
effects on normal melanocytes (Nihal et al., Int J Cancer 2005;114:513–21). EGCG (50mM)
showed greater inhibitory potency than EGC (50mM) in SE-0154, NS-1176, GE-0208 and
LF-0023 cell lines but the two catechins produced similar inhibitory effects in CH-0356,
JK-0346 and SA-1171 cell lines. The IC50 (50% inhibitory concentration) was lower for EGC
than EGCG in MB-1133 and CH-0356 cells, higher for EGC than EGCG in GE-0208 cells and
comparable (11–12mM) for both the catechins in LF-0023 cells. When compared with EGC, the
cytotoxic effect (% dead cell counts) and the suppression of the growth (change in cell number)
of all melanoma cell lines tested were pronounced with EGCG. This investigation validates the
hypothesis that anticancer action of the various catechins may vary with the type of malignancy
and provides a model for tumor cell heterogeneity based on susceptibility and resistance of
tumor cells to different green tea catechins. Therefore, this information is critical for
undertaking chemopreventive or chemotherapeutic trials against melanoma and gender-based
cancers.
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Introduction
The four major catechins in green tea (Camellia sinensis)
are epicatechin (EC), epicatechin 3-gallate (ECG),
epigallocatechin (EGC) and EGC 3-gallate (EGCG).
The dry weights of EC, ECG, EGC and EGCG are
7923, 170216, 16951 and 829592mg/100g,
in green tea, and 2401, 7614, 111624 and
11990.12mg/100g, in black tea (1). Green tea catechins
have chemopreventive potential against cancer (2–7), and
they protect against the damaging effects of ultraviolet
radiation (8).
Although ECG, EGC and EGCG can potentially sup-
press the proliferation of cancer cells (7,9–16), EGCG is
reportedly the most promising and is under clinical inves-
tigation in chemoprevention trials (3,7). We previously
found that the anticancer effects of the various catechins
in ovarian and prostate cancer cell lines varied with
the type and stage of malignancy (17). ECG was more
effective than EGCG in suppressing the growth of these
gender-based carcinomas. In contrast, recent studies of
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properly cited.human melanoma cell lines indicate that EGCG is more
potent than other catechins, and that neither EGCG nor
other catechins affect growth of normal melanocytes (7).
We hypothesize that different cancers may differ in
their susceptibility to the antitumor activity of different
green tea catechins. While prostate and ovarian carcino-
mas are susceptible to antitumor activity of ECG, human
melanoma cells may be more susceptible to the antitumor
activity of EGCG. Testing of the earlier-mentioned
hypothesis requires comparing the tumor-killing activity
of different green tea catechins on melanoma cell lines
developed from locoregional lymph nodes, the same areas
(in transit) and different distant organs.
In this investigation, we examined the ability of differ-
ent catechins to suppress the growth of eight different
human cell lines derived from locoregional lymph nodes
(two cell lines), the same areas (in transit; two cell lines)
and distant organs (four cell lines), after establishing the
cell viability, doubling time and number of cell cycles
for each cell line, as these parameters are known to vary
under different growth conditions. The goal was to
obtain data that would be useful for developing chemo-
preventive and possibly therapeutic measures for mela-
noma patients.
Materials and Methods
Human Cutaneous Melanoma Cell Lines
Eight cell lines developed from operative specimens
of regional node or distant metastatic melanoma were
used in this investigation (Table 1). All cell lines were
developed by and obtained from Ms Estella Famatiga
at the Tissue Culture Facility of John Wayne Cancer
Institute (JWCI).
All cell lines were cryopreserved and cell viability was
monitored as described earlier (17). Cells recovered from
cryovials were grown in RPMI 1640 with glutamine
(Invitrogen, Carlsbad, CA) supplemented with 10% FBS,
HEPES buffer, gentamycin (5mg%) and fungizone
(0.5mg%), at 37C in a humidified atmosphere of
5% CO2. Upon confluency, cells were detached with
sterile ethylene diamine tetra acetate (EDTA)-dextrose
(137mM sodium chloride, 5.4mM potassium chloride,
5.6mM dextrose, 0.54mM EDTA), 7.1mM sodium
bicarbonate] at 37C for 5–15min, recovered with cold
RPMI 1640–10% FBS, and resuspended in the same
medium. Cell viability and cell count were reassessed
before the cells were seeded into culture flasks.
Tea Epicatechins
All three ECs used in this study were obtained from
Sigma (ECG, Sigma E3892, FW 442.4; EGC, Sigma
E3768, FW. 306.3; EGCG, Sigma E4143, FW. 458.4) and
were >98% pure as assessed by high-performance liquid
chromatography (by the commercial source) (17). Stock
solutions were prepared under sterile conditions with 20,
40, 50 and/or 60mM of each EC or with no EC (control)
in culture medium.
Growth Conditions
In all experiments, 25ml sterile polystyrene tissue culture
flasks with a vented, blue plug seal cap (Beckton
Dickinson, Franklin Lakes, NJ, Cat. No. 353107) were
used (17). Each flask contained stock solution with or
without EC in concentrations of 50mM (four or five
flasks for each EC and four or five flasks for control) and
20, 40 and 60mM (four flasks for each EC and four flasks
for control). Cells (x10
6) suspended in 10ml of RPMI-
1640-FBS solution described earlier were transferred to
each flask and allowed to grow until the control cells
reached confluency. The culture medium was not
changed during the course of the experiment, either in
control or in experimental flasks. The cells were detached
with sterile EDTA-dextrose at 37C for 5min, recovered
with cold RPMI 1640-FBS medium, and resuspended in
the same medium. Cells were counted as described in our
previous report (17). The time interval between seeding
and confluent growth of control cells was divided by the
number of folds increased from seeding to confluence to
Table 1. Human melanoma cell lines used in this study
Sex Age at diagnosis (years) Primary site Histologic type Source of tumor cells JWCI cell line ID Passage number
M 79 Leg/hip LMM Inguinal lymph node (regional metastasis) MB-1133 8
M 39 Skin NMM Pulmonary lymph node SE-0154 11
F 42 Skin SSM Pancreas CH-0356 12
M 30 Buttocks skin SSM Liver JK-0346 22
M 40 Lower leg skin NMM Lower leg (in-transit metastasis) SA-1171 6
M 61 Nasal sinuses Unknown Nasal wall (in-transit metastasis) GE-0208 8
M 69 Neck anterior Unknown Spleen NS-1176 5
F 22 Lower leg skin SSM Proximal jejunum LF-0023 13
LMM, lentigo malignant melanoma; NMM, nodular malignant melanoma; SSM, superficially spreading melanoma.
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was calculated by dividing the confluence time by the
mean doubling time of the cell population. The 50%
inhibitory concentration (IC50) of each catechin for
each cell line was calculated using a software program
(Microcal Origin Corp, OriginLab Corporation,
Northampton, MA).
Statistics
The Kruskal–Wallis and Fisher’s least significant differ-
ence (LSD) methods were used for pairwise comparisons
of values significant at the 0.05 level. All the statistical
results are provided in the Figs 1 and 2.
Results
Two Catechins Strongly Suppress Growth of
Human Melanoma Cells
Figure 1 summarizes the mean density of cells treated
with 50mM of ECG, EGC, EGCG or no catechin. Each
mean represents four separate measurements (flasks).
In each case, the density (cell number) of treated cells
was measured when untreated (control) cells reached
confluency. Although all three catechins significantly
affected cell density, pair-wise comparison clearly identi-
fied EGC and EGCG as more potent in seven of the
eight lines. In MB-1133 cells, the inhibitory effect of
EGC or EGCG was not significantly greater than that
of ECG. Statistically, the inhibitory effects of EGC and
EGCG were comparable in CH-0356, JK-0346, SA-1171
and MB-1133 cells. However, EGCG was more potent
than EGC in SE-0154, NS-1176, GE-0208 and LF-0023
cells. LF-0023 cells were remarkably susceptible to all
three catechins.
Dosimetric Analysis of Growth Suppression
Proliferation of MB-1133, CH-0356, LF-0023 and
GE-0208 cells was assessed at EC concentrations of 0,
20, 40 and 60mM (four flasks/dose). The dosimetric
results plotted in Fig. 2 indicate that suppression of cell
growth was greatest in cells treated with high concentra-
tions (40mM) of EGC or EGCG. Catechin-mediated
growth suppression can be ranked as follows: EGCG>
EGCECG. The corresponding IC50 values, summarized
in Table 2, show a pattern distinctly different from that
found in prostate and ovarian cancer cells (17).
Tumor Cell Doubling Time: EGC Versus EGCG
Table 3 summarizes the influence of the ECs on cell
viability, percentage of dead cell count, doubling time
and cell cycle. For most of the cell lines, doubling was
not observed for cells treated with EGC or EGCG;
instead the cell number decreased, indicating cell death.
The number of cell cycles and the time taken for
confluency differed among the cell lines. EGCG was the
potent inhibitor of growth than EGC and other catechins
for CH-0356, GE-0208, JK-0346, LF-0023 and NS-1176
(mean viable cell counts after culture).
Discussion
More effective, minimally toxic systemic agents are
needed to decrease the morbidity and mortality of mela-
noma. Tea catechins appear to inhibit human melanoma
cells; both EGC and EGCG suppressed growth of human
melanoma cell line UACC-375 (10). In a recent study,
treatment with EGCG caused a dose-dependent decrease
in cell proliferation, induced apoptosis and cell cycle
arrest, and significantly inhibited colony formation of
a malignant amelanotic cell line (A-375) and a meta-
static melanoma cell line (Hs-294T), but did not affect
normal melanocytes (7). Based on these findings, it was
concluded that EGCG alone could be useful for the
management of melanoma.
Results of the present investigation based on eight
metastatic melanoma cell lines favor the view that not
a single catechin can totally arrest the growth of tumor
cells in view of the heterogeneity of cell types in a tumor
population. The data suggest that EGC together with
EGCG could be more beneficial for the management
of melanoma, because not all melanoma cells respond
identically to EGCG or any particular tea catechin. For
example, melanoma cell line LF-0023 was uniformly
susceptible to ECG, EGC and EGCG, whereas the other
cell lines differed in their susceptibility to these catechins.
The percentage dead cells observed for all the melanoma
cell lines were greater for EGCG than for any other
catechins. EGCG was, indeed, the most potent inhibitor
of cell line GE-0208; both EGCG and EGC inhibited the
growth of cell lines MB-1133, CH-0566 and LF-0023.
Overall, it appears that EGCG may be a potent inhibitor
of cell proliferation and promoter of cell death of all the
melanoma cell lines. It should be noted that the cell
population in a tumor lesion or in cell culture could be
heterogeneous in their antigen and cell surface receptor
expression and the differences observed with different
catechins may reflect such heterogeneity of the cell
population. Although it is well known that cell popula-
tion in tumor lesions or biopsies are heterogeneous,
we do not have any direct or indirect evidence to suggest
heterogeneity of the cell population in culture. Since
these cell lines used in this investigation belong to early
passages, one may anticipate prevalence of tumor cell
heterogeneity in culture.
The heterogeneous nature of the cells in a patient’s
melanoma is a strong argument for broad-based,
eCAM 2009;6(4) 525Figure 1. Antiproliferative effect of purified tea epicatechins on eight different human melanoma cell lines. Density of melanoma cells seeded
(0.21610
6 cells/CH0356; 0.29710
6 cells/MB1133; 0.25010
6/GE0208; 0.30010
6/all other cell lines) into four or five flasks containing culture
medium (RPMI-1640 with 10% FBS-antibiotics) with or without catechins (50mM). When growth of untreated cells reached confluency, cells from
each flask were harvested and viable/dead cells were counted. Mean and standard deviation are represented. P-values were obtained with pair-wise
comparison.
526 Tea epicatechins and human melanomamulti-agent systemic therapies that minimize the risk of
chemoresistance. In our studies of prostate cancer cell
lines, about 2–5% of metastatic cells failed to respond to
individual catechins (17). Although our dosimetric analy-
ses indicate that increasing the dose of catechins might
promote better tumor killing, the resistance remains a
potential problem. Heterogeneity of tumor cell popula-
tion from the perspective of susceptibility and resistance
to different green tea catechins is developed into a model
(Fig. 3). This model provides a better understanding
of the differential growth suppression of melanoma,
prostate and ovarian cancer to three different catechins.
Prostate and ovarian cancer cells are more susceptible
for ECG (A) than for EGCG (C); on the other hand,
melanoma cells appear to be more sensitive to
EGCG (C). The model elaborates the earlier-mentioned
contention. While some cells may be susceptible to all the
catechins (ABC cells in the model), one may reasonably
expect some cells to be resistant to all the catechins
(DEF cells in the model). DEF cell population may
Figure 2. Dosimetric growth suppression of human melanoma cell lines by ECG, EGC and EGCG. Cells (0.2510
6/line) were seeded in flasks
containing culture medium (RPMI-1640 with 10% FBS-antibiotics) with or without ECG or EGC or EGCG at concentrations of 0, 20, 40 and
60mM (four flasks for each dose). The horizontal line in the middle of the graph indicates IC-50. When untreated cells reached confluency,
cell monolayers in each flask were harvested and counted. P-values (Kruskal–Wallis test) indicate significant differences between mean values of
treated and untreated cells.
Table 2. IC50 values of tea catechins in melanoma, prostate and ovarian
cancer cell lines
Tumor cell line IC50 (mM)
ECG EGC EGCG
Melanoma
Nodal metastasis
MB-1133 45 35 39
Organ metastasis
CH-0356 ND 38 48
GE-0208 41 22 17
LF-0023 ND 12 11
Prostate cancer [17]
Organ-confined (HH870) 27 45
Metatastic (DU145) 24 89
Epithelial ovarian cancer [17]
Metastatic (HH450) 29 62
Metastatic (HH639) 30 42
ND, not done.
eCAM 2009;6(4) 527require other phytotherapies involving soy genistein
or turmeric curcumin or gingerol and shagalol from wet
and dry ginger or chemotherapy. The results of this
investigation suggest that a combination of catechins
might improve response and even have a synergistic
antitumor effect. Other naturally occurring, minimally
toxic agents with antitumor properties, such as
genistein, curcumin, gingerol-shagalol, crocin (saffron)
Table 3. Effects of four epicatechins (50mM) on mean viable cell count, cell cycle number, % dead cell count and doubling time of different
melanoma cell lines
Parameters Control ECG EGC EGCG
CH-0356 (21610
3 seeding/flask; 168h for confluency; five flasks/control or catechins)
Mean viable cell count (10
3) 1720347 820250 15069 11081
Dead cell count (%) 6.01.6 7.01.0 12.54.9 20.35.9
Number of cell cycles 2.950.30 1.790.45 0 0
Mean doubling time (h) 56.935.94 9424 0 0
MB-1133 (29710
3 seeding/flask; 168h for confluency; five flasks/control or catechins)
Mean viable cell count (10
3) 61370 13790 N/A 131100
Dead cell count (%) 19.782.0 39.7714.8 N/A 36.6522.9
Number of cell cycles 1.020.16 0 N/A 0
Mean doubling time (h) 164.8121.6 0 N/A 0
GE-0208 (25010
3 seeding/flask; 145h for confluency; four flasks/control or catechins)
Mean viable cell count (10
3) 1616310 106969.1 66686.1 32952.3
Dead cell count (%) 8.470.96 6.250.31 5.311.95 21.845.84
Number of cell cycles 2.650.26 2.010.09 1.38  0
Mean doubling time (h) 54.695.0 726.8 10513.7 0
JK-0346 (30010
3 seeding/flask; 120h for confluency; four flasks/control or catechins)
Mean viable cell count (10
3) 779183 27140.5 46.017.1 18.011.8
Dead cell count (%) N/A N/A N/A N/A
Number of cell cycles 1.280.34 0 0 0
Mean doubling time (h) 93.5623.4 0 0 0
LF-0023 (30010
3 seeding/flask; 185h for confluency; four flasks/control or catechins)
Mean viable cell count (10
3) 2570821 409117 11132.9 21.07.22
Dead cell count (%) 9.163.21 9.261.0 22.365.66 60.809.15
Number of cell cycles 2.970.51 0 0 0
Mean doubling time (h) 62.3811.6 0 0 0
NS-1176 (30010
3 seeding/flask; 142h for confluency; four flasks/control or catechins)
Mean viable cell count (10
3) 1303139 750125 46146.6 24917.8
Dead cell count (%) 2.920.44 4.751.00 7.040.98 18.05.6
Number of cell cycles 2.110.15 1.270.24 0 0
Mean doubling time (h) 67.474.86 11221.2 0 0
SA-1171 (25010
3 seeding/flask; 192.5h for confluency; four flasks/control or catechins)
Mean viable cell count (10
3) 80595.7 361141 10152.3 3024.8
Dead cell count (%) 19.903.58 28.112.31 25.584.30 42.1531.3
Number of cell cycles 1.670.17 0 0 0
Mean doubling time (h) 115.5912.3 0 0 0
SE-0154 (30010
3 seeding/flask; 144h for confluecy; four flasks/control or catechins)
Mean viable cell count (10
3) 926108 361101 12125.9 335.0
Dead cell count (%) 10.283.75 10.642.63 20.272.81 50.018.59
Number of cell cycles 1.610.17 0 0 0
Mean doubling time (h) 89.669.29 0 0 0
N/A, not applicable.
528 Tea epicatechins and human melanomaand apigenins, might also be incorporated in this
combination.
Administration of catechins to melanoma patients
would be an important issue. Work of Lee et al. (18)
showed that plasma levels of EGCG and EGC in healthy
volunteers increased to 78 and 223ng/ml, respectively,
20min after drinking brewed green tea (1.2g of tea solids
in 200ml hot water). This suggests that drinking more
than 10 cups of green tea may be necessary to maintain a
plasma concentration of EGCG equivalent to that used
to produce in vitro by a dose of 50mM or 22.5mg. Kaegi
(19) suggested a daily intake of 13 cups of green tea as
a chemopreventive measure. Since this level of tea
consumption is impractically high, chemoprevention of
melanoma with catechins may require administra-
tion of the appropriate catechin in a purified form.
Green tea catechins are prepared by several QC/QA-
controlled facilities in US (Nutrilite Corporation, Buena
Park, CA and possibly Life Extension Foundation,
Lauderdale, FL). However, in this in vitro study,
we have only used commercially purified green tea
catechins (Sigma, Saint Louis, MO). These purified
components of green tea catechins can be more beneficial
for chemoprevention of cancer.
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